APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pulmonary Surfactant

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pulmonary Surfactant Market Analysis and Forecast 2026-2032

23 December 2025197 pages

Choose your research edition.

Industry ResearchPulmonary Surfactant Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Pulmonary Surfactant Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Pulmonary Surfactant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pulmonary Surfactant Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pulmonary Surfactant Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pulmonary Surfactant market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pulmonary Surfactant is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pulmonary Surfactant is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pulmonary Surfactant is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pulmonary Surfactant is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pulmonary Surfactant include Abbott, Nanjing Norris Pharm Technology, AbbVie, XpressBio, Windtree Therapeutics, Tekzima (Noargen), Reddot Biotech, ONY Biotech and Lyomark Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pulmonary Surfactant, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pulmonary Surfactant, also provides the sales of main regions and countries. Of the upcoming market potential for Pulmonary Surfactant, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pulmonary Surfactant sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pulmonary Surfactant market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pulmonary Surfactant sales, projected growth trends, production technology, application and end-user industry.

Pulmonary Surfactant Segment by Company

Abbott

Nanjing Norris Pharm Technology

AbbVie

XpressBio

Windtree Therapeutics

Tekzima (Noargen)

Reddot Biotech

ONY Biotech

Lyomark Pharma

LSBio

Creative Diagnostics

Boehringer Ingelheim

Biorbyt

Biomatik

Aviva Systems Biology

Pulmonary Surfactant Segment by Type

Synthetic Pulmonary Surfactants

Animal Derived Surfactants

Pulmonary Surfactant Segment by Application

Hospital

laboratory

Others

Pulmonary Surfactant Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Surfactant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Surfactant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Surfactant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pulmonary Surfactant in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pulmonary Surfactant manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pulmonary Surfactant sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pulmonary Surfactant Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Synthetic Pulmonary Surfactants Major Manufacturers Table 3. Animal Derived Surfactants Major Manufacturers Table 4. Global Pulmonary Surfactant Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. laboratory Major Manufacturers Table 7. Others Major Manufacturers Table 8. Pulmonary Surfactant Industry Trends Table 9. Pulmonary Surfactant Industry Drivers Table 10. Pulmonary Surfactant Industry Opportunities and Challenges Table 11. Pulmonary Surfactant Industry Restraints Table 12. Global Pulmonary Surfactant Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Pulmonary Surfactant Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Pulmonary Surfactant Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Pulmonary Surfactant Revenue Market Share by Region (2021-2026) Table 16. Global Pulmonary Surfactant Revenue Market Share by Region (2027-2032) Table 17. Global Pulmonary Surfactant Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Pulmonary Surfactant Sales by Region (2021-2026) & (k units) Table 19. Global Pulmonary Surfactant Sales by Region (2027-2032) & (k units) Table 20. Global Pulmonary Surfactant Sales Market Share by Region (2021-2026) Table 21. Global Pulmonary Surfactant Sales Market Share by Region (2027-2032) Table 22. Global Pulmonary Surfactant Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Pulmonary Surfactant Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Pulmonary Surfactant Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Pulmonary Surfactant Sales Market Share by Manufacturers (2021-2026) Table 26. Global Pulmonary Surfactant Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Pulmonary Surfactant Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Pulmonary Surfactant Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Pulmonary Surfactant Manufacturers, Product Type & Application Table 30. Global Pulmonary Surfactant Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Pulmonary Surfactant by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Pulmonary Surfactant Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Pulmonary Surfactant Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Pulmonary Surfactant Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Pulmonary Surfactant Revenue Market Share by Type (2021-2026) Table 37. Global Pulmonary Surfactant Revenue Market Share by Type (2027-2032) Table 38. Global Pulmonary Surfactant Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Pulmonary Surfactant Sales by Type (2021-2026) & (k units) Table 40. Global Pulmonary Surfactant Sales by Type (2027-2032) & (k units) Table 41. Global Pulmonary Surfactant Sales Market Share by Type (2021-2026) Table 42. Global Pulmonary Surfactant Sales Market Share by Type (2027-2032) Table 43. Global Pulmonary Surfactant Price by Type (2021-2026) & (US$/unit) Table 44. Global Pulmonary Surfactant Price by Type (2027-2032) & (US$/unit) Table 45. Global Pulmonary Surfactant Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Pulmonary Surfactant Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Pulmonary Surfactant Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Pulmonary Surfactant Revenue Market Share by Application (2021-2026) Table 49. Global Pulmonary Surfactant Revenue Market Share by Application (2027-2032) Table 50. Global Pulmonary Surfactant Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Pulmonary Surfactant Sales by Application (2021-2026) & (k units) Table 52. Global Pulmonary Surfactant Sales by Application (2027-2032) & (k units) Table 53. Global Pulmonary Surfactant Sales Market Share by Application (2021-2026) Table 54. Global Pulmonary Surfactant Sales Market Share by Application (2027-2032) Table 55. Global Pulmonary Surfactant Price by Application (2021-2026) & (US$/unit) Table 56. Global Pulmonary Surfactant Price by Application (2027-2032) & (US$/unit) Table 57. Abbott Company Information Table 58. Abbott Business Overview Table 59. Abbott Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Abbott Pulmonary Surfactant Product Portfolio Table 61. Abbott Recent Development Table 62. Nanjing Norris Pharm Technology Company Information Table 63. Nanjing Norris Pharm Technology Business Overview Table 64. Nanjing Norris Pharm Technology Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolio Table 66. Nanjing Norris Pharm Technology Recent Development Table 67. AbbVie Company Information Table 68. AbbVie Business Overview Table 69. AbbVie Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. AbbVie Pulmonary Surfactant Product Portfolio Table 71. AbbVie Recent Development Table 72. XpressBio Company Information Table 73. XpressBio Business Overview Table 74. XpressBio Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. XpressBio Pulmonary Surfactant Product Portfolio Table 76. XpressBio Recent Development Table 77. Windtree Therapeutics Company Information Table 78. Windtree Therapeutics Business Overview Table 79. Windtree Therapeutics Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Windtree Therapeutics Pulmonary Surfactant Product Portfolio Table 81. Windtree Therapeutics Recent Development Table 82. Tekzima (Noargen) Company Information Table 83. Tekzima (Noargen) Business Overview Table 84. Tekzima (Noargen) Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Tekzima (Noargen) Pulmonary Surfactant Product Portfolio Table 86. Tekzima (Noargen) Recent Development Table 87. Reddot Biotech Company Information Table 88. Reddot Biotech Business Overview Table 89. Reddot Biotech Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Reddot Biotech Pulmonary Surfactant Product Portfolio Table 91. Reddot Biotech Recent Development Table 92. ONY Biotech Company Information Table 93. ONY Biotech Business Overview Table 94. ONY Biotech Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. ONY Biotech Pulmonary Surfactant Product Portfolio Table 96. ONY Biotech Recent Development Table 97. Lyomark Pharma Company Information Table 98. Lyomark Pharma Business Overview Table 99. Lyomark Pharma Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Lyomark Pharma Pulmonary Surfactant Product Portfolio Table 101. Lyomark Pharma Recent Development Table 102. LSBio Company Information Table 103. LSBio Business Overview Table 104. LSBio Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. LSBio Pulmonary Surfactant Product Portfolio Table 106. LSBio Recent Development Table 107. Creative Diagnostics Company Information Table 108. Creative Diagnostics Business Overview Table 109. Creative Diagnostics Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Creative Diagnostics Pulmonary Surfactant Product Portfolio Table 111. Creative Diagnostics Recent Development Table 112. Boehringer Ingelheim Company Information Table 113. Boehringer Ingelheim Business Overview Table 114. Boehringer Ingelheim Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Boehringer Ingelheim Pulmonary Surfactant Product Portfolio Table 116. Boehringer Ingelheim Recent Development Table 117. Biorbyt Company Information Table 118. Biorbyt Business Overview Table 119. Biorbyt Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Biorbyt Pulmonary Surfactant Product Portfolio Table 121. Biorbyt Recent Development Table 122. Biomatik Company Information Table 123. Biomatik Business Overview Table 124. Biomatik Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Biomatik Pulmonary Surfactant Product Portfolio Table 126. Biomatik Recent Development Table 127. Aviva Systems Biology Company Information Table 128. Aviva Systems Biology Business Overview Table 129. Aviva Systems Biology Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Aviva Systems Biology Pulmonary Surfactant Product Portfolio Table 131. Aviva Systems Biology Recent Development Table 132. North America Pulmonary Surfactant Revenue by Type (2021-2026) & (US$ Million) Table 133. North America Pulmonary Surfactant Revenue by Type (2027-2032) & (US$ Million) Table 134. North America Pulmonary Surfactant Sales by Type (2021-2026) & (k units) Table 135. North America Pulmonary Surfactant Sales by Type (2027-2032) & (k units) Table 136. North America Pulmonary Surfactant Sales Price by Type (2021-2026) & (US$/unit) Table 137. North America Pulmonary Surfactant Sales Price by Type (2027-2032) & (US$/unit) Table 138. North America Pulmonary Surfactant Revenue by Application (2021-2026) & (US$ Million) Table 139. North America Pulmonary Surfactant Revenue by Application (2027-2032) & (US$ Million) Table 140. North America Pulmonary Surfactant Sales by Application (2021-2026) & (k units) Table 141. North America Pulmonary Surfactant Sales by Application (2027-2032) & (k units) Table 142. North America Pulmonary Surfactant Sales Price by Application (2021-2026) & (US$/unit) Table 143. North America Pulmonary Surfactant Sales Price by Application (2027-2032) & (US$/unit) Table 144. North America Pulmonary Surfactant Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Pulmonary Surfactant Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. North America Pulmonary Surfactant Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. North America Pulmonary Surfactant Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 148. North America Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 149. North America Pulmonary Surfactant Sales by Country (2027-2032) & (k units) Table 150. North America Pulmonary Surfactant Sales Price by Country (2021-2026) & (US$/unit) Table 151. North America Pulmonary Surfactant Sales Price by Country (2027-2032) & (US$/unit) Table 152. United States Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 153. Canada Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 154. Mexico Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 155. Europe Pulmonary Surfactant Revenue by Type (2021-2026) & (US$ Million) Table 156. Europe Pulmonary Surfactant Revenue by Type (2027-2032) & (US$ Million) Table 157. Europe Pulmonary Surfactant Sales by Type (2021-2026) & (k units) Table 158. Europe Pulmonary Surfactant Sales by Type (2027-2032) & (k units) Table 159. Europe Pulmonary Surfactant Sales Price by Type (2021-2026) & (US$/unit) Table 160. Europe Pulmonary Surfactant Sales Price by Type (2027-2032) & (US$/unit) Table 161. Europe Pulmonary Surfactant Revenue by Application (2021-2026) & (US$ Million) Table 162. Europe Pulmonary Surfactant Revenue by Application (2027-2032) & (US$ Million) Table 163. Europe Pulmonary Surfactant Sales by Application (2021-2026) & (k units) Table 164. Europe Pulmonary Surfactant Sales by Application (2027-2032) & (k units) Table 165. Europe Pulmonary Surfactant Sales Price by Application (2021-2026) & (US$/unit) Table 166. Europe Pulmonary Surfactant Sales Price by Application (2027-2032) & (US$/unit) Table 167. Europe Pulmonary Surfactant Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Europe Pulmonary Surfactant Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. Europe Pulmonary Surfactant Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. Europe Pulmonary Surfactant Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 171. Europe Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 172. Europe Pulmonary Surfactant Sales by Country (2027-2032) & (k units) Table 173. Europe Pulmonary Surfactant Sales Price by Country (2021-2026) & (US$/unit) Table 174. Europe Pulmonary Surfactant Sales Price by Country (2027-2032) & (US$/unit) Table 175. Germany Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 176. France Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 177. U.K. Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 178. Italy Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 179. Russia Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 180. Spain Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 181. Netherlands Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 182. Switzerland Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 183. Sweden Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 184. Poland Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 185. China Pulmonary Surfactant Revenue by Type (2021-2026) & (US$ Million) Table 186. China Pulmonary Surfactant Revenue by Type (2027-2032) & (US$ Million) Table 187. China Pulmonary Surfactant Sales by Type (2021-2026) & (k units) Table 188. China Pulmonary Surfactant Sales by Type (2027-2032) & (k units) Table 189. China Pulmonary Surfactant Sales Price by Type (2021-2026) & (US$/unit) Table 190. China Pulmonary Surfactant Sales Price by Type (2027-2032) & (US$/unit) Table 191. China Pulmonary Surfactant Revenue by Application (2021-2026) & (US$ Million) Table 192. China Pulmonary Surfactant Revenue by Application (2027-2032) & (US$ Million) Table 193. China Pulmonary Surfactant Sales by Application (2021-2026) & (k units) Table 194. China Pulmonary Surfactant Sales by Application (2027-2032) & (k units) Table 195. China Pulmonary Surfactant Sales Price by Application (2021-2026) & (US$/unit) Table 196. China Pulmonary Surfactant Sales Price by Application (2027-2032) & (US$/unit) Table 197. Asia Pulmonary Surfactant Revenue by Type (2021-2026) & (US$ Million) Table 198. Asia Pulmonary Surfactant Revenue by Type (2027-2032) & (US$ Million) Table 199. Asia Pulmonary Surfactant Sales by Type (2021-2026) & (k units) Table 200. Asia Pulmonary Surfactant Sales by Type (2027-2032) & (k units) Table 201. Asia Pulmonary Surfactant Sales Price by Type (2021-2026) & (US$/unit) Table 202. Asia Pulmonary Surfactant Sales Price by Type (2027-2032) & (US$/unit) Table 203. Asia Pulmonary Surfactant Revenue by Application (2021-2026) & (US$ Million) Table 204. Asia Pulmonary Surfactant Revenue by Application (2027-2032) & (US$ Million) Table 205. Asia Pulmonary Surfactant Sales by Application (2021-2026) & (k units) Table 206. Asia Pulmonary Surfactant Sales by Application (2027-2032) & (k units) Table 207. Asia Pulmonary Surfactant Sales Price by Application (2021-2026) & (US$/unit) Table 208. Asia Pulmonary Surfactant Sales Price by Application (2027-2032) & (US$/unit) Table 209. Asia Pulmonary Surfactant Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. Asia Pulmonary Surfactant Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. Asia Pulmonary Surfactant Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. Asia Pulmonary Surfactant Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 213. Asia Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 214. Asia Pulmonary Surfactant Sales by Country (2027-2032) & (k units) Table 215. Asia Pulmonary Surfactant Sales Price by Country (2021-2026) & (US$/unit) Table 216. Asia Pulmonary Surfactant Sales Price by Country (2027-2032) & (US$/unit) Table 217. Japan Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 218. South Korea Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 219. India Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 220. Australia Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 221. Taiwan Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 222. Southeast Asia Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 223. SAMEA Pulmonary Surfactant Revenue by Type (2021-2026) & (US$ Million) Table 224. SAMEA Pulmonary Surfactant Revenue by Type (2027-2032) & (US$ Million) Table 225. SAMEA Pulmonary Surfactant Sales by Type (2021-2026) & (k units) Table 226. SAMEA Pulmonary Surfactant Sales by Type (2027-2032) & (k units) Table 227. SAMEA Pulmonary Surfactant Sales Price by Type (2021-2026) & (US$/unit) Table 228. SAMEA Pulmonary Surfactant Sales Price by Type (2027-2032) & (US$/unit) Table 229. SAMEA Pulmonary Surfactant Revenue by Application (2021-2026) & (US$ Million) Table 230. SAMEA Pulmonary Surfactant Revenue by Application (2027-2032) & (US$ Million) Table 231. SAMEA Pulmonary Surfactant Sales by Application (2021-2026) & (k units) Table 232. SAMEA Pulmonary Surfactant Sales by Application (2027-2032) & (k units) Table 233. SAMEA Pulmonary Surfactant Sales Price by Application (2021-2026) & (US$/unit) Table 234. SAMEA Pulmonary Surfactant Sales Price by Application (2027-2032) & (US$/unit) Table 235. SAMEA Pulmonary Surfactant Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 236. SAMEA Pulmonary Surfactant Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 237. SAMEA Pulmonary Surfactant Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 238. SAMEA Pulmonary Surfactant Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 239. SAMEA Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 240. SAMEA Pulmonary Surfactant Sales by Country (2027-2032) & (k units) Table 241. SAMEA Pulmonary Surfactant Sales Price by Country (2021-2026) & (US$/unit) Table 242. SAMEA Pulmonary Surfactant Sales Price by Country (2027-2032) & (US$/unit) Table 243. Brazil Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 244. Argentina Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 245. Chile Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 246. Colombia Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 247. Peru Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 248. Saudi Arabia Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 249. Israel Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 250. UAE Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 251. Turkey Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 252. Iran Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 253. Egypt Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Table 254. Key Raw Materials Table 255. Raw Materials Key Suppliers Table 256. Pulmonary Surfactant Distributors List Table 257. Pulmonary Surfactant Customers List Table 258. Research Programs/Design for This Report Table 259. Authors List of This Report Table 260. Secondary Sources Table 261. Primary Sources List of Figures Figure 1. Pulmonary Surfactant Image Figure 2. Global Pulmonary Surfactant Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pulmonary Surfactant Market Size Share 2021 VS 2025 VS 2032 Figure 4. Synthetic Pulmonary Surfactants Image Figure 5. Animal Derived Surfactants Image Figure 6. Global Pulmonary Surfactant Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pulmonary Surfactant Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. laboratory Image Figure 10. Others Image Figure 11. Global Pulmonary Surfactant Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Figure 13. Global Pulmonary Surfactant Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Pulmonary Surfactant Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Pulmonary Surfactant Revenue Market Share by Region (2021-2032) Figure 16. Global Pulmonary Surfactant Sales (2021-2032) & (k units) Figure 17. Global Pulmonary Surfactant Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Pulmonary Surfactant Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Pulmonary Surfactant Sales YoY (2021-2032) & (k units) Figure 20. Europe Pulmonary Surfactant Sales YoY (2021-2032) & (k units) Figure 21. China Pulmonary Surfactant Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Pulmonary Surfactant Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Pulmonary Surfactant Sales YoY (2021-2032) & (k units) Figure 24. Global Pulmonary Surfactant Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Pulmonary Surfactant Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Pulmonary Surfactant Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Pulmonary Surfactant Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Pulmonary Surfactant Revenue Market Share by Type (2021-2032) Figure 30. Global Pulmonary Surfactant Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Pulmonary Surfactant Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Pulmonary Surfactant Sales Market Share by Type (2021-2032) Figure 33. Global Pulmonary Surfactant Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Pulmonary Surfactant Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Pulmonary Surfactant Revenue Market Share by Application (2021-2032) Figure 36. Global Pulmonary Surfactant Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Pulmonary Surfactant Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Pulmonary Surfactant Sales Market Share by Application (2021-2032) Figure 39. North America Pulmonary Surfactant Revenue Share by Type (2021-2032) Figure 40. North America Pulmonary Surfactant Sales Share by Type (2021-2032) Figure 41. North America Pulmonary Surfactant Revenue Share by Application (2021-2032) Figure 42. North America Pulmonary Surfactant Sales Share by Application (2021-2032) Figure 43. North America Pulmonary Surfactant Revenue Share by Country (2021-2032) Figure 44. North America Pulmonary Surfactant Sales Share by Country (2021-2032) Figure 45. Europe Pulmonary Surfactant Revenue Share by Type (2021-2032) Figure 46. Europe Pulmonary Surfactant Sales Share by Type (2021-2032) Figure 47. Europe Pulmonary Surfactant Revenue Share by Application (2021-2032) Figure 48. Europe Pulmonary Surfactant Sales Share by Application (2021-2032) Figure 49. Europe Pulmonary Surfactant Revenue Share by Country (2021-2032) Figure 50. Europe Pulmonary Surfactant Sales Share by Country (2021-2032) Figure 51. China Pulmonary Surfactant Revenue Share by Type (2021-2032) Figure 52. China Pulmonary Surfactant Sales Share by Type (2021-2032) Figure 53. China Pulmonary Surfactant Revenue Share by Application (2021-2032) Figure 54. China Pulmonary Surfactant Sales Share by Application (2021-2032) Figure 55. Asia Pulmonary Surfactant Revenue Share by Type (2021-2032) Figure 56. Asia Pulmonary Surfactant Sales Share by Type (2021-2032) Figure 57. Asia Pulmonary Surfactant Revenue Share by Application (2021-2032) Figure 58. Asia Pulmonary Surfactant Sales Share by Application (2021-2032) Figure 59. Asia Pulmonary Surfactant Revenue Share by Country (2021-2032) Figure 60. Asia Pulmonary Surfactant Sales Share by Country (2021-2032) Figure 61. SAMEA Pulmonary Surfactant Revenue Share by Type (2021-2032) Figure 62. SAMEA Pulmonary Surfactant Sales Share by Type (2021-2032) Figure 63. SAMEA Pulmonary Surfactant Revenue Share by Application (2021-2032) Figure 64. SAMEA Pulmonary Surfactant Sales Share by Application (2021-2032) Figure 65. SAMEA Pulmonary Surfactant Revenue Share by Country (2021-2032) Figure 66. SAMEA Pulmonary Surfactant Sales Share by Country (2021-2032) Figure 67. Pulmonary Surfactant Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Pulmonary Surfactant Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Synthetic Pulmonary Surfactants
  • Animal Derived Surfactants
Applications
  • Hospital
  • laboratory
  • Others
Companies covered
  • Abbott
  • Nanjing Norris Pharm Technology
  • AbbVie
  • XpressBio
  • Windtree Therapeutics
  • Tekzima (Noargen)
  • Reddot Biotech
  • ONY Biotech
  • Lyomark Pharma
  • LSBio
  • Creative Diagnostics
  • Boehringer Ingelheim
  • Biorbyt
  • Biomatik
  • Aviva Systems Biology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pulmonary Surfactant Market by Type
  3. 1.2.1 Global Pulmonary Surfactant Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Synthetic Pulmonary Surfactants
  5. 1.2.3 Animal Derived Surfactants
  6. 1.3 Pulmonary Surfactant Market by Application
  7. 1.3.1 Global Pulmonary Surfactant Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 laboratory
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pulmonary Surfactant Market Dynamics
  1. 2.1 Pulmonary Surfactant Industry Trends
  2. 2.2 Pulmonary Surfactant Industry Drivers
  3. 2.3 Pulmonary Surfactant Industry Opportunities and Challenges
  4. 2.4 Pulmonary Surfactant Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pulmonary Surfactant Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pulmonary Surfactant Revenue by Region
  3. 3.2.1 Global Pulmonary Surfactant Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pulmonary Surfactant Revenue by Region (2021-2026)
  5. 3.2.3 Global Pulmonary Surfactant Revenue by Region (2027-2032)
  6. 3.2.4 Global Pulmonary Surfactant Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pulmonary Surfactant Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pulmonary Surfactant Sales by Region
  9. 3.4.1 Global Pulmonary Surfactant Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pulmonary Surfactant Sales by Region (2021-2026)
  11. 3.4.3 Global Pulmonary Surfactant Sales by Region (2027-2032)
  12. 3.4.4 Global Pulmonary Surfactant Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pulmonary Surfactant Revenue by Manufacturers
  2. 4.1.1 Global Pulmonary Surfactant Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pulmonary Surfactant Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pulmonary Surfactant Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pulmonary Surfactant Sales by Manufacturers
  6. 4.2.1 Global Pulmonary Surfactant Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pulmonary Surfactant Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pulmonary Surfactant Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pulmonary Surfactant Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pulmonary Surfactant Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pulmonary Surfactant Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pulmonary Surfactant Manufacturers, Product Type & Application
  13. 4.7 Global Pulmonary Surfactant Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pulmonary Surfactant Market CR5 and HHI
  16. 4.8.2 2025 Pulmonary Surfactant Tier 1, Tier 2, and Tier 3
5 Pulmonary Surfactant Market by Type
  1. 5.1 Global Pulmonary Surfactant Revenue by Type
  2. 5.1.1 Global Pulmonary Surfactant Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pulmonary Surfactant Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pulmonary Surfactant Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pulmonary Surfactant Sales by Type
  6. 5.2.1 Global Pulmonary Surfactant Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pulmonary Surfactant Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Pulmonary Surfactant Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pulmonary Surfactant Price by Type
6 Pulmonary Surfactant Market by Application
  1. 6.1 Global Pulmonary Surfactant Revenue by Application
  2. 6.1.1 Global Pulmonary Surfactant Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pulmonary Surfactant Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pulmonary Surfactant Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pulmonary Surfactant Sales by Application
  6. 6.2.1 Global Pulmonary Surfactant Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pulmonary Surfactant Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Pulmonary Surfactant Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pulmonary Surfactant Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Pulmonary Surfactant Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Nanjing Norris Pharm Technology
  8. 7.2.1 Nanjing Norris Pharm Technology Company Information
  9. 7.2.2 Nanjing Norris Pharm Technology Business Overview
  10. 7.2.3 Nanjing Norris Pharm Technology Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolio
  12. 7.2.5 Nanjing Norris Pharm Technology Recent Developments
  13. 7.3 AbbVie
  14. 7.3.1 AbbVie Company Information
  15. 7.3.2 AbbVie Business Overview
  16. 7.3.3 AbbVie Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 AbbVie Pulmonary Surfactant Product Portfolio
  18. 7.3.5 AbbVie Recent Developments
  19. 7.4 XpressBio
  20. 7.4.1 XpressBio Company Information
  21. 7.4.2 XpressBio Business Overview
  22. 7.4.3 XpressBio Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 XpressBio Pulmonary Surfactant Product Portfolio
  24. 7.4.5 XpressBio Recent Developments
  25. 7.5 Windtree Therapeutics
  26. 7.5.1 Windtree Therapeutics Company Information
  27. 7.5.2 Windtree Therapeutics Business Overview
  28. 7.5.3 Windtree Therapeutics Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Windtree Therapeutics Pulmonary Surfactant Product Portfolio
  30. 7.5.5 Windtree Therapeutics Recent Developments
  31. 7.6 Tekzima (Noargen)
  32. 7.6.1 Tekzima (Noargen) Company Information
  33. 7.6.2 Tekzima (Noargen) Business Overview
  34. 7.6.3 Tekzima (Noargen) Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Tekzima (Noargen) Pulmonary Surfactant Product Portfolio
  36. 7.6.5 Tekzima (Noargen) Recent Developments
  37. 7.7 Reddot Biotech
  38. 7.7.1 Reddot Biotech Company Information
  39. 7.7.2 Reddot Biotech Business Overview
  40. 7.7.3 Reddot Biotech Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Reddot Biotech Pulmonary Surfactant Product Portfolio
  42. 7.7.5 Reddot Biotech Recent Developments
  43. 7.8 ONY Biotech
  44. 7.8.1 ONY Biotech Company Information
  45. 7.8.2 ONY Biotech Business Overview
  46. 7.8.3 ONY Biotech Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 ONY Biotech Pulmonary Surfactant Product Portfolio
  48. 7.8.5 ONY Biotech Recent Developments
  49. 7.9 Lyomark Pharma
  50. 7.9.1 Lyomark Pharma Company Information
  51. 7.9.2 Lyomark Pharma Business Overview
  52. 7.9.3 Lyomark Pharma Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Lyomark Pharma Pulmonary Surfactant Product Portfolio
  54. 7.9.5 Lyomark Pharma Recent Developments
  55. 7.10 LSBio
  56. 7.10.1 LSBio Company Information
  57. 7.10.2 LSBio Business Overview
  58. 7.10.3 LSBio Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 LSBio Pulmonary Surfactant Product Portfolio
  60. 7.10.5 LSBio Recent Developments
  61. 7.11 Creative Diagnostics
  62. 7.11.1 Creative Diagnostics Company Information
  63. 7.11.2 Creative Diagnostics Business Overview
  64. 7.11.3 Creative Diagnostics Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Creative Diagnostics Pulmonary Surfactant Product Portfolio
  66. 7.11.5 Creative Diagnostics Recent Developments
  67. 7.12 Boehringer Ingelheim
  68. 7.12.1 Boehringer Ingelheim Company Information
  69. 7.12.2 Boehringer Ingelheim Business Overview
  70. 7.12.3 Boehringer Ingelheim Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Boehringer Ingelheim Pulmonary Surfactant Product Portfolio
  72. 7.12.5 Boehringer Ingelheim Recent Developments
  73. 7.13 Biorbyt
  74. 7.13.1 Biorbyt Company Information
  75. 7.13.2 Biorbyt Business Overview
  76. 7.13.3 Biorbyt Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Biorbyt Pulmonary Surfactant Product Portfolio
  78. 7.13.5 Biorbyt Recent Developments
  79. 7.14 Biomatik
  80. 7.14.1 Biomatik Company Information
  81. 7.14.2 Biomatik Business Overview
  82. 7.14.3 Biomatik Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Biomatik Pulmonary Surfactant Product Portfolio
  84. 7.14.5 Biomatik Recent Developments
  85. 7.15 Aviva Systems Biology
  86. 7.15.1 Aviva Systems Biology Company Information
  87. 7.15.2 Aviva Systems Biology Business Overview
  88. 7.15.3 Aviva Systems Biology Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Aviva Systems Biology Pulmonary Surfactant Product Portfolio
  90. 7.15.5 Aviva Systems Biology Recent Developments
8 North America
  1. 8.1 North America Pulmonary Surfactant Market Size by Type
  2. 8.1.1 North America Pulmonary Surfactant Revenue by Type (2021-2032)
  3. 8.1.2 North America Pulmonary Surfactant Sales by Type (2021-2032)
  4. 8.1.3 North America Pulmonary Surfactant Price by Type (2021-2032)
  5. 8.2 North America Pulmonary Surfactant Market Size by Application
  6. 8.2.1 North America Pulmonary Surfactant Revenue by Application (2021-2032)
  7. 8.2.2 North America Pulmonary Surfactant Sales by Application (2021-2032)
  8. 8.2.3 North America Pulmonary Surfactant Price by Application (2021-2032)
  9. 8.3 North America Pulmonary Surfactant Market Size by Country
  10. 8.3.1 North America Pulmonary Surfactant Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pulmonary Surfactant Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pulmonary Surfactant Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pulmonary Surfactant Market Size by Type
  2. 9.1.1 Europe Pulmonary Surfactant Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pulmonary Surfactant Sales by Type (2021-2032)
  4. 9.1.3 Europe Pulmonary Surfactant Price by Type (2021-2032)
  5. 9.2 Europe Pulmonary Surfactant Market Size by Application
  6. 9.2.1 Europe Pulmonary Surfactant Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pulmonary Surfactant Sales by Application (2021-2032)
  8. 9.2.3 Europe Pulmonary Surfactant Price by Application (2021-2032)
  9. 9.3 Europe Pulmonary Surfactant Market Size by Country
  10. 9.3.1 Europe Pulmonary Surfactant Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pulmonary Surfactant Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pulmonary Surfactant Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pulmonary Surfactant Market Size by Type
  2. 10.1.1 China Pulmonary Surfactant Revenue by Type (2021-2032)
  3. 10.1.2 China Pulmonary Surfactant Sales by Type (2021-2032)
  4. 10.1.3 China Pulmonary Surfactant Price by Type (2021-2032)
  5. 10.2 China Pulmonary Surfactant Market Size by Application
  6. 10.2.1 China Pulmonary Surfactant Revenue by Application (2021-2032)
  7. 10.2.2 China Pulmonary Surfactant Sales by Application (2021-2032)
  8. 10.2.3 China Pulmonary Surfactant Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pulmonary Surfactant Market Size by Type
  2. 11.1.1 Asia Pulmonary Surfactant Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pulmonary Surfactant Sales by Type (2021-2032)
  4. 11.1.3 Asia Pulmonary Surfactant Price by Type (2021-2032)
  5. 11.2 Asia Pulmonary Surfactant Market Size by Application
  6. 11.2.1 Asia Pulmonary Surfactant Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pulmonary Surfactant Sales by Application (2021-2032)
  8. 11.2.3 Asia Pulmonary Surfactant Price by Application (2021-2032)
  9. 11.3 Asia Pulmonary Surfactant Market Size by Country
  10. 11.3.1 Asia Pulmonary Surfactant Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pulmonary Surfactant Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pulmonary Surfactant Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pulmonary Surfactant Market Size by Type
  2. 12.1.1 SAMEA Pulmonary Surfactant Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pulmonary Surfactant Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pulmonary Surfactant Price by Type (2021-2032)
  5. 12.2 SAMEA Pulmonary Surfactant Market Size by Application
  6. 12.2.1 SAMEA Pulmonary Surfactant Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pulmonary Surfactant Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pulmonary Surfactant Price by Application (2021-2032)
  9. 12.3 SAMEA Pulmonary Surfactant Market Size by Country
  10. 12.3.1 SAMEA Pulmonary Surfactant Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pulmonary Surfactant Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pulmonary Surfactant Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pulmonary Surfactant Value Chain Analysis
  2. 13.1.1 Pulmonary Surfactant Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pulmonary Surfactant Production Mode & Process
  6. 13.2 Pulmonary Surfactant Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pulmonary Surfactant Distributors
  9. 13.2.3 Pulmonary Surfactant Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst